381

Compound name
Erlotinib
Alt Name
Tarceva
Compound Image
Erlotinib.png
SMILES
COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
Brutto
C22H23N3O4
InChI
InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)
InChI Key
AAKJLRGGTJKAMG-UHFFFAOYSA-N
Approval Jurisdiction
2004 NSCLC
Approved for clinical use
Pancreatic Cancer
CAS
183321-74-6
PubChem CID
176870
Action
EGFR
Approved Drug List
1
Commercial Vendor
Genemtech Roche